Bank Of America Corp Logic Bio Therapeutics, Inc. Transaction History

Bank Of America Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.35 - $0.74 $301 - $637	-861 Reduced 99.88%	1 $0
Q1 2022 May 16, 2022	SELL	$0.61 - $2.49 $2,339 - $9,549	-3,835 Reduced 81.65%	862 $1,000
Q4 2021 Feb 08, 2022	SELL	$2.2 - $4.53 $4,419 - $9,100	-2,009 Reduced 29.96%	4,697 $11,000
Q3 2021 Nov 15, 2021	SELL	$3.85 - $5.09 $13,032 - $17,229	-3,385 Reduced 33.54%	6,706 $31,000
Q2 2021 Sep 13, 2021	BUY	$4.03 - $7.57 $40,666 - $76,388	10,091 New	10,091 $45,000

Ticker LOGC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,962,700
Description
LogicBio Therapeutics, Inc., a genetic medicine company, focuses on developing and commercializing genome editing and gene therapy treatments using its GeneRide and sAAVy platforms. The company's GeneRide technology is a new approach to precise gene insertion harnessing a cell's natural deoxyribonucleic acid; and gene delivery platform, sAAVy is...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.